Nature Reviews Endocrinology

Article	Citations
The largest study of genetics of T1DM	531
A protective role for insulin in acute pancreatitis	506
Nonenzymatic prevention of insulin hyperresponsiveness by FBP1	479
Anti-PIT1 hypophysitis after immune checkpoint inhibitor treatment	454
Increasing success of islet transplantation	320
CNOT6L regulates hepatokine expression	312
The relationship between the gut microbiota and thyroid disorders	308
FAPs linked with muscle degeneration in T2DM	301
Glycogen involved in browning of adipocytes	287
Ageing immune cells reduce adipose tissue function	286
A role for circulating levels of uridine in regulating hunger and food intake	257
Aster pathway maintains hepatic cholesterol homeostasis	257
Differences in stem cell-derived islets	240
Ghrelin’s effects on growth hormone release: to pulse or not to pulse?	238
Dexamethasone in patients with diabetes mellitus	210
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations	198
Memory of obesity stored in adipocytes	152
Immune cell population prevents weight regain	149
GWAS gives insights into glucose regulation	147
Exercise-induced plasma factors confer brain benefits	146
Fetal orchestration of maternal metabolism via IGF2	139
Caution needed: paracetamol use in pregnancy	137
Phase IIa results for potential NAFLD therapy	130
GLP1-mediated delivery of tesaglitazar improves glucose metabolism in mice	129
Exposing skin to ultraviolet irradiation increases food intake in male individuals	124

Interventions in people newly diagnosed with type 1 diabetes mellitus	119
Bile acid species shows potential for NAFLD	113
Origins of the ‘KNDy hypothesis’ of GnRH pulse generation	113
Low brown adipose tissue activity linked to NAFLD	111
A century of glucagon	109
Obesity-associated ASB4 controls satiety	107
Mitochondria transported from adipocytes in extracellular vesicles	107
Uncovering how the GnRH pulse generator is controlled in female mice	106
Effects of diet on atherosclerotic plaque development	106
Non-nutritive sweeteners — too sweet to be wholesome?	106
Timed high-fat diet feeding restores small bowel circadian rhythms	100
Unravelling the molecular basis of futile creatine cycling	99
A mitochondrial trigger for beige adipocyte development	97
Adrenal cysts: an emerging condition	96
The enduring relevance of the Randle cycle	95
New insights on regulatory T cell decline in obesity	93
Exploring the functions of the myokine feimin	93
The complexity of adipocyte heterogeneity	91
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia	88
Statins and diabetes mellitus progression: a fly in the ointment?	87
Identification of thermogenic adipocyte lineages	86
New genes associated with adult-onset obesity	83
Phospholipid biosynthetic pathways and lipodystrophies: a novel syndrome due to PLAAT3 deficiency	82
Metabolic control of puberty: 60 years in the footsteps of Kennedy and Mitra’s seminal work	79
TIM4+ adipose tissue-resident macrophages: new modulators of adiposity	78
PPAR mediates intestinal stem cell tumorigenesis	76
CITED1 mediates sex-specific regulation of food intake in hypothalamic neurons	72
Liver–bone crosstalk implicated in osteoporosis progression	72
A perspective on treating type 1 diabetes mellitus before insulin is needed	71
Brain–immune networks: a role for GLP1 receptor	71
Do psychedelics have therapeutic potential for obesity?	69
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer	67
Diagnosis of gestational diabetes mellitus: the debate continues	66
Co-agonist therapeutics come of age for obesity	66
The role of DNA damage in diabetic complications	66
The influence of the circulatory system on tissue ageing: does the fountain of youth lie in our blood?	65
Thyroid function and iodine intake: global recommendations and relevant dietary trends	65
Medically not yet explained symptoms in hypothyroidism	63
Sex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus	61
Paracetamol use in pregnancy — caution over causal inference from available data	59
Machine intelligence in non-invasive endocrine cancer diagnostics	58
Reply to ‘Paracetamol use in pregnancy — neglecting context promotes misinterpretation’	56
Non-invasive daily profiles of tissue adrenal steroids	50
Is combined exercise and incretin-based therapy the way forward for weight-loss maintenance?	50
On the cutting edge: perspectives in bioenergetics	50
Urban built environments: interventions for reducing cardiometabolic risks	49
The discovery of human monogenic obesity	49
Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss	48
SGLT inhibitors: a serendipitous glycaemic tale	48
Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement	46

The challenges of assessing adiposity in a clinical setting	45
Publisher Correction: Current understanding of the molecular and cellular pathology of diabetic retinopathy	43
Lactate as a major myokine and exerkine	43
Adipose tissue lipolysis controlled by endothelial cells	42
Limiting the use and misuse of liothyronine in hypothyroidism	42
Highlights from SfE BES 2021	40
The epidemiology of type 1 diabetes mellitus in older adults	40
Highlights from the Joint Irish–UK Endocrine Meeting 2024	40
Author Correction: Growth hormone-releasing hormone and its analogues in health and disease	40
Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults	39
Neutrophils might link intestinal damage to retinopathy in type 2 diabetes mellitus	39
Brown adipose tissue fights the battle against leukaemia	39
The individual response to antibiotics and diet — insights into gut microbial resilience and host metabolism	38
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases	38
Is calorie labelling on menus the solution to obesity?	36
Approaches to addressing the rise in obesity levels	36
Programming of metabolism by adipokines during development	36
Heterogeneity and endotypes in type 1 diabetes mellitus	34
Epigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment	33
The regulation of endocrine-disrupting chemicals to minimize their impact on health	32
Harnessing the inflammatory processes in endometriosis	32
Strategies for modelling endometrial diseases	32
The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action	31
The gut microbiota in obesity and weight management: microbes as friends or foe?	31
Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia	31
Obesity-induced and weight-loss-induced physiological factors affecting weight regain	29
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead	28
Type 2 diabetes mellitus in older adults: clinical considerations and management	28
Exerkines in health, resilience and disease	27
Variation in metformin pharmacokinetics	26
Succinate signalling regulates leptin production in adipocytes	26
To fast or not to fast — that is the question	26
Autocrine FGF21 signalling promotes beiging	26
Exploring the regulation of glucagon secretion	25
Cause of rare form of Cushing syndrome found	25
New treatment target for endometriosis	25
Syntaxin 4 — protective in β-cells in T1DM?	25
Hepatic T helper 17 cells implicated in NAFLD	24
Feasibility and effectiveness of time-restricted eating in different populations	24
Role for IL-17A in adipocyte biology	24
Obesity phenotypes: explaining the unexplained	23
Functional HNF1A variants linked with T2DM risk in European-ancestry populations	23
Metabolite levels during the menstrual cycle	22
Lipidomics reveals early markers	22
Brain insulin action in women	22
Neurons in the diagonal band of Broca moderate food intake	21
Insulin receptor sets liver clock	21
Female-specific inflammatory signalling exacerbates central nervous system autoimmunity in obesity	20
Ketosis improves muscle stem cell resilience	19
Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health	18
Lactation duration affects obesity risk in rat offspring	17
Iron in adipocytes — a role in gut–adipose crosstalk	17
Optimising stem cells for diabetes mellitus therapy	17
Antivirals in the treatment of new-onset T1DM	16
Defining subpopulations of human adipose tissue progenitor cells	16
SRC2 controls the refeeding response in mice	16
New mechanism of Cushing disease revealed	16
Negative regulator of GDF15 signalling identified	16
Metformin reduces ageing adipose senescence	14
Role for exosomes in insulin sensitivity	14
Engineering stem cells to recapitulate thyroid cancer	14
Function of a common FTO variant in vivo	14
Precision medicine approach improves HbA1c outcomes in T2DM	14
Opposing neuropeptides control cAMP signalling to regulate satiety	13
Osteal macrophages implicated in osteoporosis	13
PDL1 reduces adipose inflammation in obesity	13
Post-burn endocrine–immune dynamics and ageing considerations	13
The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease	13
DDIT4 contributes to macrophage reprogramming	13
Novel therapies with precision mechanisms for type 2 diabetes mellitus	13
Sex differences in diabetic kidney disease explained	13
Probing α-cell dysfunction in type 2 diabetes mellitus	13
Health equity in endocrinology	12
How COVID-19 disrupts glycometabolic control	12
Advances in the management of achondroplasia	12
Combination therapy increases human β-cell mass in vivo	12
High-intensity exercise training — too much of a good thing?	12
Endocrinology in the multi-omics era	12
Author Correction: Optoacoustic imaging in endocrinology and metabolism	12
Research in metabolic ageing — a tale of mice versus humans?	11

The interactions between energy homeostasis and neurovascular plasticity	11
Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus	11
Knowledge in youth is wisdom in age: involving young people in research	11
Glucagon receptor antagonists might stimulate β-cell expansion	10
Detouring adrenergic stimulation to induce adipose thermogenesis	10
The genetics of autoimmune Addison disease: past, present and future	9
Oxytocin regulates adipose tissue lipolysis	9
Skeletal muscle loss and sarcopenia in obesity pharmacotherapy	9
Dietary fructose acts on gut to increase nutrient uptake	9
The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults	9
Masterful papers that broke open understanding of reproductive neuroendocrinology	8
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia	8
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations	8
Patients’ insights into diabetes insipidus	8
The importance of human brown adipose tissue volume	8
Glial control of neuronal function	8
Could leptin substitution therapy potentially terminate entrapment in anorexia nervosa?	8
A pivotal year for NAFLD and NASH therapeutics	8
Controlling brown adipose tissue size through EPAC1	8
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia	7
Examining how our brain determines gender identity	7
Hypoparathyroidism: diagnosis, management and emerging therapies	7
Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy	7
Relugolix — new treatment for uterine fibroid-related heavy bleeding	7
Metabolic effects of gender-affirming hormone therapy	7
The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects	7
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease	6
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1	6
Circulating non-coding RNA biomarkers of endocrine tumours	6
Metabolomic profiling of adrenal function in asthma	6
Linking liver alanine metabolism and muscle atrophy	6
Insulin detection in diabetes mellitus: challenges and new prospects	6
One hundred years of insulin therapy	6
The role of insufficient sleep and circadian misalignment in obesity	6
Primary aldosteronism — a multidimensional syndrome	6
Diet composition affects mitochondria trafficking in adipose tissue	6
The complex effects of dietary restriction on longevity and health	5
Environmental factors in declining human fertility	5
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus	5
Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus	5
Early life factors that affect obesity and the need for complex solutions	5
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity	5
Skeletal disorders associated with the growth hormone–insulin-like growth factor 1 axis	5
Genomic alterations in thyroid cancer: biological and clinical insights	5
Applying the WHO global targets for diabetes mellitus	5
Autophagy in metabolic disease and ageing	5
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus	5
Emerging mechanisms of obesity-associated immune dysfunction	5
Consensus Statement on the definition and classification of metabolic hyperferritinaemia	5
Oxytocin deficiency — a ‘new’ human disorder?	5
Steroid hormones as modulators of anti-tumoural immunity	5
An integrated model of obesity pathogenesis that revisits causal direction	5
AMPK as a mediator of tissue preservation: time for a shift in dogma?	5
Metabolic regulation of skeletal cell fate and function	5
FGF1 signalling cascade suppresses lipolysis	5
A role for HDAC6 in leptin sensitivity	4
GLP1 acts on an inter-organ neural circuit	4
A role for phosphocreatine in adipose inflammation	4
GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus	4
Dysfunctional lipid metabolism in ageing muscle: effects on glucose tolerance	4
Urocortin 3 function in glucose metabolism	4
Senescent immune cells promote skeletal ageing	4
New BAT–liver endocrine pathway via succinate	4
Macrophage and T cell networks in adipose tissue	4
Highlights from ADA 82nd Scientific Sessions	4
Cognitive function in T1DM improved by hybrid closed-loop insulin delivery	4
Genetic risk scores improve prediction of obesity in survivors of childhood cancer	4
Unravelling adipose tissue fibrosis in obesity	4
An exercise-induced metabolite alters feeding	4
New drug target identified for β-cell dysfunction	4
Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits	4
RalA links obesity and mitochondrial dysfunction	4
Role of extracellular vesicles in β-cell failure	4
β-adrenergic receptors feel the heat against obesity	3
Paracetamol use in pregnancy — neglecting context promotes misinterpretation	3
Advanced neurobiological tools to interrogate metabolism	3
A new endometrial organoid: synthetically engineered matrix enhances epithelial–stromal interactions	3
The emerging role of lipidomics in prediction of diseases	3
Slowly progressive insulin-dependent diabetes mellitus in type 1 diabetes endotype 2	3
Pancreatic mesenchymal stem cells might protect β-cells	3
New role for bone marrow adipocytes in obesity	3
Publisher Correction: Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency	3
Metabolic elasticity — a new trait associated with health?	3
Adipose tissue boosts muscle regeneration by supplying mesenchymal stromal cells	3
Uncovering the origin of oxidative damage in ischaemia–reperfusion injury in the heart	3
Reply to ‘Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern’	3
The metabolic mythos of ketones	3
Approval of teplizumab: implications for patients	3
Key role for gut microbiota in PCOS development	3
Debunking the myths of intermittent fasting	3
Progress in islet transplantation is more important than ever	3
Beyond the ovary: rewiring our perspective on polycystic ovary syndrome	3
PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus	3
Author Correction: Targeting the incretin system in obesity and type 2 diabetes mellitus	3
Follistatin linked to type 2 diabetes mellitus risk	3